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showed no signs of recurrence during the 10 years following distal
gastrectomy. The occurrence of her last menstrual period was un-
clear because of irregular vaginal bleeding. At the ﬁrst clinical ex-
amination, genital bleeding was present and the patient bled
easily from her uterine cervix. A transvaginal sonography revealed
a 22 × 20 mm high echoic lesion at the dorsal side of the cervix.
Biochemical blood examination results were all within normal
limits, but the level of squamous cell carcinoma-related antigenIntroduction
Late recurrence of gastric cancer after curative resection is rare.
Distant metastasis to the uterine cervix is also quite rare, especially
from extrapelvic organs (Abrams et al., 1950; Lemoine and Hall, 1986).
Despite its rarity, it is important to consider the possibility of metastasis
from gastric cancer to the uterine cervix if a female patient experiences
genital bleeding or presents with a cervical tumor. Here, we present a
case of gastric cancermetastasis to the uterine cervix 10 years after distal
gastrectomy.Case description
A 46-year-old woman, gravida 2 para 2, presented to our hospital
with a complaint of irregular genital bleeding and a 27.1 × 20.7 mm
uterine cervix tumor, whichwas detected on pelvicmagnetic resonance
imaging (MRI). One year prior to the present event, her cervical and en-
dometrial cytology had been negative, and a pelvic MRI examination
had shown normal ﬁndings (Fig. 1a). Ten years prior, the patient had
undergone adjuvant chemotherapy following distal gastrectomy for
pathologically diagnosed stage IIIB poorly differentiated gastric adenocar-
cinoma. The exact pathological stage of disease was pT3N2M0 according
to the 5th edition Union for International Cancer Control (UICC)
classiﬁcation, and pT4aN2M0 according to the 7th edition UICC
classiﬁcation.Department of Obstetrics and
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c. Open access under CC BY-NC-ND license. was slightly elevated at 2.4 ng/mL. The result of a high-risk human
papillomavirus (HPV)–DNA hybrid capture test was negative. Nei-
ther an upper gastrointestinal nor a colon ﬁberscopy showed any
evidence of abnormalities.
A Papanicolaou (Pap) smear of the uterine cervix revealed atypi-
cal glandular cells, and a biopsy specimen taken from the uterine cer-
vix indicated poorly differentiated adenocarcinoma, which made us
suspect recurrence of the previous gastric cancer. Pelvic MRI showed
a high-intensity 27.1 × 20.7 mm irregular mass on T2-weighted
images of the cervix (Fig. 1b). Fluorine-18-ﬂuorodeoxyglucose
(18F-FDG) positron emission computed tomography did not show
increased FDG uptake in the uterine cervix or other organs. Accord-
ingly, the patient was diagnosed as having gastric cancer metastasis
to the uterine cervix. Modiﬁed radical hysterectomy with bilateral
salpingo-oophorectomy was performed with a curative intent and
for diagnostic conﬁrmation. Intraoperative examination did not re-
veal any ascitic ﬂuid, palpable lymph nodes, or peritoneal seeding.
The pathological diagnosis was metastatic adenocarcinoma in the
uterine cervix, originating from the known gastric cancer. Subse-
quently, a postoperative Pap smear revealed atypical glandular
cells because of residual tumor in the vaginal stump. First, the regi-
menwith S-1 (tegafur, gimeracil and oteracil potassium) and cisplat-
in, which is one of the standard regimens for a recurrent gastric
cancer in Japan, was presented to the patient however she didn't ac-
cept it because of the side effect. Therefore, chemotherapy with S-1
was originally planned to be administered daily for the ﬁrst week
of every 3-week cycle. However, the administration schedule was re-
duced due to side effects. The patient eventually received adjuvant
chemotherapy with 100 mg/day S-1 administered daily during the
ﬁrst week of every 6-week cycle for 1 year. Pap smear results became
negative for an intraepithelial lesion after chemotherapy. Follow-up
computed tomography scans have not indicated any recurring
tumor to date. At the time of this report, the patient remains alive
and is believed to have achieved complete response 24 months
after surgery.
Fig. 1. Pelvic magnetic resonance images. (a) No abnormalities are evident 1 year before the patient was referred to our hospital. (b) A mass in the uterine cervix is observed at the time of
admission.
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A mass with a focus on the dorsal side of the uterine cervix was
observed. The tumor cells producedmucus and formed clusters, theﬁnd-
ings are consistent with a poorly differentiated adenocarcinoma (the
same type of adenocarcinoma as the patient's previous gastric cancer).
The tumor cells mainly developed in the uterine cervical stroma, rather
than in the epithelia of the uterine cervix (Fig. 2). An immunohistochem-
ical analysis of the specimenwasperformed. Cancer cells stainedpositive
for cytokeratin (CK) 7, CK20, carcinoembryonic antigen (CEA), mucin
(MUC) 2, CDX2, p16 and p53, but negative for MUC1, MUC5 and
MUC6. There was no evidence of cancer cells in the ovaries or the
fallopian tubes. Tumor cellswere not observed onperitonealwashing cy-
tology analysis. Therefore, the patient was diagnosed with metastasis
from the previous gastric cancer to the uterine cervix, involving the uter-
ine corpus, vagina and uterosacral ligament.
Discussion
Metastasis from extrapelvic organs to the uterine cervix is rare.
Abrams et al. reported that metastatic involvement of the uterine cervixFig. 2.Microscopic ﬁndings of metastatic adenocarcinoma at the uterine cervix. (a) Heoccurred in only 3 of 1000 cases of metastatic cancer (Abrams et al.,
1950). It has also been reported that, of all metastases to the uterine
cervix except for the result of direct extension of a primary tumor,
36.4% originated from ovarian cancer, 30.3% from colorectal cancer,
15.2% from gastric cancer, 12.1% from breast cancer, 3.0% from renal
cell cancer, and 3.0% from transitional cell cancer of the renal pelvis
(Lemoine and Hall, 1986). The reason why incidence of metastasis to
the uterine cervix is low remains unclear. However, Lemoine et al. sug-
gested that this low incidence might result from an abundance of
ﬁbrous matrix and a low degree of vascularity (Lemoine and Hall,
1986). To our knowledge, only one case has been previously reported
on the diagnosis of an isolatedmetastasis of gastric cancer to the uterine
cervix by surgical specimens (Yokoyama et al., 2000). To identify relevant
case reports,we searchedPubMed for cases ofmetastatic gastric cancer to
the uterine cervix, and reviewed 39 such cases from 7 references listed in
Table 1 (Lemoine and Hall, 1986; Yokoyama et al., 2000; Perez-Montiel
et al., 2012; Imachi et al., 1993; Matsuura et al., 1997; Zhang et al.,
1983; Kashimura et al., 1983). In the following paragraphs, we present
a summary of these cases.
Among patients with cervical metastases, the median age at the time
of metastasis diagnosis was 44 years (range, 23–75 years), and only 9matoxylin and eosin staining, 100×. (b) Hematoxylin and eosin staining, 400 × .
Table 1
Metastases to the uterine cervix from gastric cancer.
Number of cases 39 Cervical cytology, No (%)
Positive 19 (61.3)
Age Mets (years) Negative 12 (38.7)
Median 44 Not reported 8
Range 23–75
Histology of metastatic cervical tumor, No (%)
Metastatic sites documented (36 cases), No. (%) SRC 22 (64.7)
Ovary 27 (75.0) PD 7 (20.6)
Peritoneum 12 (33.3) UD 1 (2.9)
Douglas mass 8 (22.2) UD + SRC 3 (8.8)
Cervix alone 2 (5.5) PD + tubular 1 (2.9)
Not reported 5
Clinical stage of the primary gastric cancer, No (%)
I 1 (5.3) P/M Interval (months)
II 0 Median 22
III 0 Range 1–121
IV 18 (94.7)
Not reported 20 Survival (months)
Dead (25 cases)
Symptoms, No (%) Median 4
Atypical genital bleeding 14 (35.8) Range 0–33
Abdominal pain 8 (20.5) Alive (8 cases)
Abdominal mass 4 (10.2) Median 4
Other 8 (20.5) Range 1–8
No symptom 2 (5.1) Not reported (6 cases)
Metastatic sites includedmultiple cases. Cervical cytology positive; cancer cells or atypical cells were observed. SRC, signet ring cells; PD, poorly differentiated; UD, undifferentiated. P/M
interval; interval between the diagnosis of primary gastric cancer and metastatic cervical tumor in 22 recurrent cases.
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Hall, 1986; Yokoyama et al., 2000; Perez-Montiel et al., 2012; Imachi et al.,
1993; Matsuura et al., 1997; Zhang et al., 1983; Kashimura et al., 1983).
Therefore, we speculate that high blood ﬂow to the uterine cervix could
be an important factor in cases of cervical metastasis of gastric cancer.
Themajor histological types ofmetastatic gastric cancer are signet ring
adenocarcinoma (64.7% of cases) and poorly differentiated adenocarcino-
ma (20.6% of cases) (Yokoyama et al., 2000; Perez-Montiel et al., 2012;
Imachi et al., 1993; Matsuura et al., 1997; Zhang et al., 1983; Kashimura
et al., 1983). At the time of presentation, the most common chief com-
plaint was atypical genital bleeding, followed by abdominal pain. Pap
smears may be a useful method for diagnosing metastases of gastric can-
cer to the uterine cervix, because abnormal cytological ﬁndings such as
cancer cells or atypical glandular cells were observed in 19 of 31 cases
(61.3%) (Yokoyama et al., 2000; Perez-Montiel et al., 2012; Imachi et al.,
1993; Matsuura et al., 1997; Zhang et al., 1983; Kashimura et al., 1983).
Inmost cases involvingmetastasis of gastric cancer to the uterine cer-
vix, the primary gastric cancer was classiﬁed as stage IV and had poor
prognosis.Median survival from the time of diagnosis of cervicalmetasta-
sis was only 4 months (range, 0–33 months). Of 36 cases, 34 also in-
volved other extrauterine metastatic sites, including the ovaries (27
cases; 75.0%), the peritoneum(12 cases; 33.3%), and the pouch of Douglas
(8 cases; 22.2%) (Lemoine and Hall, 1986; Yokoyama et al., 2000; Perez-
Montiel et al., 2012; Imachi et al., 1993; Matsuura et al., 1997; Zhang
et al., 1983; Kashimura et al., 1983). Only one case was found to be
a cervical metastasis from a gastric cancer without extrauterine metasta-
sis, based onpostsurgical pathologicalﬁndings (Yokoyama et al., 2000). In
the other case, the diagnosis was only conﬁrmed via biopsy (Perez-
Montiel et al., 2012). Accordingly, metastasis of gastric cancer to the uter-
ine cervix without the involvement of extrauterine metastatic sites is
quite rare. Yet, the case we reported here had this feature.
Gastric cancer recurrence usually occurs within 2 years of treatment
(75.4%) and the recurrence rates after N5 years and N7 years are only
5.7% and 2.1%, respectively (Shiraishi et al., 2000). In 22 recurrent
cases, the median interval between the diagnosis of primary gastric
cancer and the diagnosis of the cervical metastasis was 22 months
(range, 1–121 months) (Lemoine and Hall, 1986; Yokoyama et al.,
2000; Perez-Montiel et al., 2012; Imachi et al., 1993; Matsuura et al.,
1997; Zhang et al., 1983; Kashimura et al., 1983). Therefore, recurrence10 years after the diagnosis of primary gastric cancer, as in our case, is
extremely rare.
When choosing a therapeutic strategy, it is important to distinguish
primary tumors from metastases. In our case, the cervical tumor was a
poorly differentiated adenocarcinoma, which has the same histological
type as the primary gastric cancer. Immunohistochemical analysis re-
vealed that tumor cells stained positive for CK7, CK20, CDX2 and CEA.
These results are much more likely to be observed in gastric cancer
than in primary cervical adenocarcinoma, although we couldn't know
which the primary gastric adenocarcinoma was stained for CDX2 and
the other marker due to a lack of access to the primary specimen for
re-staining. In addition, the overall prevalence of high-risk HPV (types
16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68) in primary cervical
adenocarcinoma is 91.1% (Castellsague et al., 2006). Yet, a high-risk
HPV–DNA testwas negative in our case. On the other hand, an immuno-
histochemical analysis showed the tumor cells stained positive for p16,
as one of amarker for HPV infection, and negative in the normal cervical
glands. The results seem to conﬂict, however, gastric cancers were also
positive for p16 in 75% of cases (Schneider et al., 2000), again suggesting
that the cancer was not a primary cervical adenocarcinoma. Based on
this ﬁnding, we suggest that high-risk HPV–DNA testing could be valu-
able in diagnosing metastasis of adenocarcinoma to the uterine cervix.
We selected a modiﬁed hysterectomy, which resected the
parametrium broadly but did not resect the vaginal side. However, un-
fortunately the margin was slightly positive. Therefore the adjuvant
chemotherapy was needed.
In conclusion,metastasis fromextrapelvic organs to the uterine cervix
should be considered during differential diagnosis of a female patient
with genital bleeding or cervical tumors, even in cases of carcinoma treat-
ment many years prior to the presentation of such symptoms.
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